These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30904563)

  • 1. The genomics of schizophrenia: Shortcomings and solutions.
    Zhuo C; Hou W; Li G; Mao F; Li S; Lin X; Jiang D; Xu Y; Tian H; Wang W; Cheng L
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():71-76. PubMed ID: 30904563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Genomics Identify a Regulatory Risk Variation rs4420550 in the 16p11.2 Schizophrenia-Associated Locus.
    Chang H; Cai X; Li HJ; Liu WP; Zhao LJ; Zhang CY; Wang JY; Liu JW; Ma XL; Wang L; Yao YG; Luo XJ; Li M; Xiao X
    Biol Psychiatry; 2021 Feb; 89(3):246-255. PubMed ID: 33246552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of Schizophrenia: Ready to Translate?
    Foley C; Corvin A; Nakagome S
    Curr Psychiatry Rep; 2017 Sep; 19(9):61. PubMed ID: 28741255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.
    Rudan I
    Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances and perspectives on the use of CRISPR/Cas9 systems in plant genomics research.
    Liu D; Hu R; Palla KJ; Tuskan GA; Yang X
    Curr Opin Plant Biol; 2016 Apr; 30():70-7. PubMed ID: 26896588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unlocking the treasure trove: from genes to schizophrenia biology.
    McCarthy SE; McCombie WR; Corvin A
    Schizophr Bull; 2014 May; 40(3):492-6. PubMed ID: 24674812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings.
    Kotlar AV; Mercer KB; Zwick ME; Mulle JG
    Eur J Med Genet; 2015 Dec; 58(12):704-14. PubMed ID: 26493318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Big Data and Genome Editing Technology: A New Paradigm of Cardiovascular Genomics.
    Krittanawong C; Sun T; Herzog E
    Curr Cardiol Rev; 2017; 13(4):301-304. PubMed ID: 28782493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Search for risk genes in schizophrenia].
    Rujescu D
    Nervenarzt; 2017 Jul; 88(7):751-754. PubMed ID: 28429076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The applications of CRISPR screen in functional genomics.
    Qi X; Zhang J; Zhao Y; Chen T; Xiang Y; Hui J; Cai D; Liu Y; Xia L; Yu T; Li G
    Brief Funct Genomics; 2017 Jan; 16(1):34-37. PubMed ID: 27329784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic findings in schizophrenia and their implications.
    Owen MJ; Legge SE; Rees E; Walters JTR; O'Donovan MC
    Mol Psychiatry; 2023 Sep; 28(9):3638-3647. PubMed ID: 37853064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Value of Genomic Copy Number Variations in Schizophrenia.
    Zhuo C; Hou W; Lin C; Hu L; Li J
    Front Mol Neurosci; 2017; 10():204. PubMed ID: 28680393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent genomic advances in schizophrenia.
    Doherty JL; O'Donovan MC; Owen MJ
    Clin Genet; 2012 Feb; 81(2):103-9. PubMed ID: 21895634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diving into marine genomics with CRISPR/Cas9 systems.
    Momose T; Concordet JP
    Mar Genomics; 2016 Dec; 30():55-65. PubMed ID: 27742404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics of schizophrenia].
    Jitoku D; Yoshikawa T
    Nihon Rinsho; 2013 Apr; 71(4):599-604. PubMed ID: 23678585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
    Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
    Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches to insights of susceptibility genes.
    Lv Y; Wen L; Hu WJ; Deng C; Ren HW; Bao YN; Su BW; Gao P; Man ZY; Luo YY; Li CJ; Xiang ZX; Wang B; Luan ZL
    Metab Brain Dis; 2024 Jan; 39(1):147-171. PubMed ID: 37542622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.